252 related articles for article (PubMed ID: 28689321)
81. Ultrasonographic predictors of thyroid cancer in Bethesda III and IV thyroid nodules.
Alyusuf EY; Alhmayin L; Albasri E; Enani J; Altuwaijri H; Alsomali N; Arafah MA; Alyusuf Z; Jammah AA; Ekhzaimy AA; Alzahrani AS
Front Endocrinol (Lausanne); 2024; 15():1326134. PubMed ID: 38405143
[TBL] [Abstract][Full Text] [Related]
82. Concordance between thyroid nodule sizes measured by ultrasound and gross pathology examination: effect on patient management.
Deveci MS; Deveci G; LiVolsi VA; Gupta PK; Baloch ZW
Diagn Cytopathol; 2007 Sep; 35(9):579-83. PubMed ID: 17703450
[TBL] [Abstract][Full Text] [Related]
83. Preoperative detection of RAS mutation may guide extent of thyroidectomy.
Patel SG; Carty SE; McCoy KL; Ohori NP; LeBeau SO; Seethala RR; Nikiforova MN; Nikiforov YE; Yip L
Surgery; 2017 Jan; 161(1):168-175. PubMed ID: 27863786
[TBL] [Abstract][Full Text] [Related]
84. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
[TBL] [Abstract][Full Text] [Related]
85. Re-visiting the ATA 2015 sonographic guidelines - who are we missing?: A retrospective review.
Chan DS; Gong K; Roskies MG; Forest VI; Hier MP; Payne RJ
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):51. PubMed ID: 30176940
[TBL] [Abstract][Full Text] [Related]
86. Evaluation of PACE4 isoforms as biomarkers in thyroid cancer.
Fradet L; Temmar R; Couture F; Belzile M; Fortier PH; Day R
J Otolaryngol Head Neck Surg; 2018 Oct; 47(1):63. PubMed ID: 30340539
[TBL] [Abstract][Full Text] [Related]
87. Economic Impact of Frozen Section for Thyroid Nodules with "Suspicious for Malignancy" Cytology.
Bollig CA; Gilley D; Lesko D; Jorgensen JB; Galloway TL; Zitsch RP; Dooley LM
Otolaryngol Head Neck Surg; 2018 Feb; 158(2):257-264. PubMed ID: 29292662
[TBL] [Abstract][Full Text] [Related]
88. Effect of thyroid nodule size on cytology reliability and incidence of malignancy: A large cohort of 1205 patients from a single center.
Sencar ME; Calapkulu M; Bostan H; Sakiz D; Hepsen S; Kizilgul M; Unsal IO; Ozcelik O; Arslan E; Ucan B; Azili C; Ozbek M; Cakal E
Ann Endocrinol (Paris); 2023 Apr; 84(2):238-241. PubMed ID: 36126756
[TBL] [Abstract][Full Text] [Related]
89. Limitation of intraoperative frozen section during thyroid surgery.
Estebe S; Montenat C; Tremoureux A; Rousseau C; Bouilloud F; Jegoux F
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1671-1676. PubMed ID: 27913858
[TBL] [Abstract][Full Text] [Related]
90. Association of Bethesda category and molecular mutation in patients undergoing thyroidectomy.
Mascarella MA; Peeva M; Forest VI; Pusztaszeri MP; Avior G; Tamilia M; Mlynarek AM; Hier MP; Payne RJ
Clin Otolaryngol; 2022 Jan; 47(1):75-80. PubMed ID: 34510770
[TBL] [Abstract][Full Text] [Related]
91. The national rate of malignancy among Bethesda III, IV, and V thyroid nodules is higher than expected: A NSQIP analysis.
Delman AM; Turner KM; Ammann AM; Sisak S; Farooqui Z; Holm TM
Surgery; 2023 Mar; 173(3):645-652. PubMed ID: 36229250
[TBL] [Abstract][Full Text] [Related]
92. Thyroid nodules with indeterminate cytology: association between nodule size, histopathological characteristics and clinical outcome in differentiated thyroid carcinomas - a multicenter retrospective cohort study on 761 patients.
Cozzani F; Bettini D; Rossini M; Bonati E; Nuzzo S; Loderer T; Pedrazzi G; Zaccaroni A; Del Rio P
Updates Surg; 2021 Oct; 73(5):1923-1930. PubMed ID: 34100186
[TBL] [Abstract][Full Text] [Related]
93. Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.
Angell TE; Vyas CM; Barletta JA; Cibas ES; Cho NL; Doherty GM; Gawande AA; Howitt BE; Krane JF; Marqusee E; Strickland KC; Alexander EK; Moore FD; Nehs MA
Ann Surg Oncol; 2018 May; 25(5):1410-1417. PubMed ID: 29520656
[TBL] [Abstract][Full Text] [Related]
94. Risk of thyroid carcinoma in patients treated surgically with assumed benign cytology in Riyadh, Saudi Arabia.
Al Essa M; Doubi A; Aldosari L; Alkhaldi A; Alzahrani M; Alsadi M; Alsalem A
Acta Otorhinolaryngol Ital; 2022 Jun; 42(3):237-242. PubMed ID: 35880364
[TBL] [Abstract][Full Text] [Related]
95. The solitary thyroid nodule revisited.
Wong TH; Ong CL; Tan WT; Rauff A
Ann Acad Med Singap; 1993 Jul; 22(4):593-7. PubMed ID: 8257066
[TBL] [Abstract][Full Text] [Related]
96. Malignancy in Solitary Thyroid Nodule.
Majumder KR; Karmakar R; Karim SS; Al-Mamun A
Mymensingh Med J; 2016 Jan; 25(1):39-44. PubMed ID: 26931247
[TBL] [Abstract][Full Text] [Related]
97. Predictors of Malignancy in Thyroid Nodules.
Islam MR; Ahmed S; Mostafa MG; Khan L; Alam MM; Alam A; Ahmed MB; Rahman MA
Mymensingh Med J; 2022 Apr; 31(2):372-378. PubMed ID: 35383753
[TBL] [Abstract][Full Text] [Related]
98. Trends in the Surgical Management of Known or Suspected Differentiated Thyroid Cancer at a Single Institution, 2010-2018.
Zhu CY; Sha SW; Tseng CH; Yang SE; Orr LE; Levin M; Wong CW; Livhits MJ; Rao J; Yeh MW
Thyroid; 2020 Nov; 30(11):1639-1645. PubMed ID: 32515290
[No Abstract] [Full Text] [Related]
99. The gray zone of thyroid nodules: Using a nomogram to provide malignancy risk assessment and guide patient management.
Yousefi E; Sura GH; Somma J
Cancer Med; 2021 Apr; 10(8):2723-2731. PubMed ID: 33763983
[TBL] [Abstract][Full Text] [Related]
100. Impact of oncogene panel results on surgical management of cytologically indeterminate thyroid nodules.
Valderrabano P; Khazai L; Thompson ZJ; Leon ME; Otto KJ; Hallanger-Johnson JE; Wadsworth JT; Chung CH; Centeno BA; McIver B
Head Neck; 2018 Aug; 40(8):1812-1823. PubMed ID: 29624786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
